News

Goldman Sachs said: “India presents an attractive region for clinical trials given a population of over one billion, a large number of English-speaking patients, and a well developed

In May 2006, Mannatech filed a lawsuit against Techmedica and Ionx in the US District Court for the Northern District of Texas, Dallas Division, alleging infringement of its

Cardiac Science, with an installed customer base of more than 65,000 diagnostic monitoring devices, can connect its devices with Medent systems for a smooth transfer of test results.

Cell-IQ, developed by Finnish company, Chip-Man Technologies, is already being successfully employed in prestigious universities and institutes across Europe and Asia, and is now exclusively available via TAP

The first antibody conjugate is Nimotuzumab coupled to a radionuclide, indium-111, and a cell-nucleus delivery system developed in the laboratory of Dr. Raymond Reilly, Professor, Leslie Dan Faculty

Corvert injection (Ibutilide fumarate injection) is an antiarrhythmic drug with predominantly class III (cardiac action potential prolongation) properties according to the Vaughan Williams Classification. Each milliliter of Corvert

The phase 3 trial will enroll no option as well as poor option patients with chronic and severe ischemia of the lower limb. No option patients are those

The acquisition of MRT, with its patented approach to high throughput miniature bioreactor equipment and disposables, expands Pall’s Total Fluid Management(TFM) capabilities in the $1 billion biopharmaceuticals process

Synergy will be implementing PharmaVigilant’s Inspire EDC System, Clinical Data Warehouse, Investigator Portal and I-Vault eTMF system to support the preparation, conduct and closeout of their phase II